Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluvalAB Seasonal Influenza Vaccine Serologic Clinical Trial 2008-2009
2008-003655-74Phase 4Completed
- Sponsor
- Omninvest
- Start
- Jun 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Fluval AB Novo in influenza, sponsored by Omninvest. Primary endpoint: Seroconversion ratio by age group. Started Jun 2008; status: completed.
02
Drugs
Fluval AB Novo
03
Conditions
influenza
Beyond the preview
Go deeper on 2008-003655-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003655-74.